MyAverix Finance
SHE · Healthcare
Wecome Pharmaceutical Co Ltd (300878)
Biotechnology
Wecome Pharmaceutical Co Ltd (300878) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $4.04B, P/E ratio is 18.00, net margin is -239.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300878
Wecome Pharmaceutical Co Ltd (300878) — FAQ
What is Wecome Pharmaceutical Co Ltd's market cap?
Wecome Pharmaceutical Co Ltd (300878) has a reported market cap of $4.04B (data as of 2026-03-28).
What is 300878's P/E ratio?
The price-to-earnings (P/E) ratio for Wecome Pharmaceutical Co Ltd (300878) is 18.00 (data as of 2026-03-28).
Does Wecome Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Wecome Pharmaceutical Co Ltd (300878). Check the MyAverix Finance app for the latest dividend data.
What sector is Wecome Pharmaceutical Co Ltd in?
Wecome Pharmaceutical Co Ltd (300878) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 300878 listed on?
300878 is listed on SHE.
What is Wecome Pharmaceutical Co Ltd's net margin?
Wecome Pharmaceutical Co Ltd (300878) reports a net margin of -239.5% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.